References
Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44: S14–21
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106: 3143–421
Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004, 27: 1496–1504.
Garvey WT, Kwon S, Zheng D, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003, 52: 453–62.
Masson LF, McNeill G, Avenell A. Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 2003, 77: 1098–111.
Ukkola O, Salonen J, Kesäniemi YA. Role of candidate genes in the lipid responses to intensified treatment in type 2 diabetes. J Endocr Invest 2005, 28: 871–5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baroni, M.G. Diabetic dyslipidemia and response to intensified glycemic treatment: Why there are differences?. J Endocrinol Invest 28, 869–870 (2005). https://doi.org/10.1007/BF03345316
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345316